Bard Associates Inc. decreased its position in shares of The Joint Corp. (NASDAQ:JYNT – Free Report) by 1.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 84,050 shares of the company’s stock after selling 1,384 shares during the period. Bard Associates Inc.’s holdings in Joint were worth $962,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Los Angeles Capital Management LLC purchased a new stake in Joint during the second quarter valued at about $1,115,000. Clayton Partners LLC grew its holdings in Joint by 38.1% during the second quarter. Clayton Partners LLC now owns 186,500 shares of the company’s stock valued at $2,622,000 after purchasing an additional 51,500 shares during the last quarter. Ancora Advisors LLC raised its holdings in Joint by 105.0% in the 1st quarter. Ancora Advisors LLC now owns 99,212 shares of the company’s stock worth $1,296,000 after acquiring an additional 50,815 shares during the period. First Foundation Advisors lifted its position in Joint by 18.8% during the 1st quarter. First Foundation Advisors now owns 209,301 shares of the company’s stock worth $2,733,000 after acquiring an additional 33,104 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in Joint by 5.5% during the second quarter. Renaissance Technologies LLC now owns 394,478 shares of the company’s stock valued at $5,546,000 after acquiring an additional 20,400 shares during the period. 76.88% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several analysts recently weighed in on JYNT shares. StockNews.com upgraded Joint from a “hold” rating to a “buy” rating in a research note on Friday. Roth Mkm lowered their price target on Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, November 8th.
Joint Stock Performance
Joint stock opened at $11.22 on Friday. The business has a 50-day moving average of $11.31 and a 200-day moving average of $12.96. The Joint Corp. has a 1 year low of $8.29 and a 1 year high of $17.82.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Read More
- Five stocks we like better than Joint
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Top-Performing Non-Leveraged ETFs This Year
- The Most Important Warren Buffett Stock for Investors: His Own
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- 3 Fintech Stocks With Good 2021 Prospects
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Want to see what other hedge funds are holding JYNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Joint Corp. (NASDAQ:JYNT – Free Report).
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.